title: Atrial fibrillation, valvular heart disease, and use of target-specific oral anticoagulants for stroke prevention.
authors.affiliation: J.W. Goethe University, Department of Cardiology, Frankfurt, Germany and Duke Clinical Research Institute, Duke Medicine, Durham, NC, USA Hohnloser@em.uni-frankfurt.de.
authors.forename: Stefan H
authors.initials: SH
authors.lastname: Hohnloser
authors.affiliation: J.W. Goethe University, Department of Cardiology, Frankfurt, Germany and Duke Clinical Research Institute, Duke Medicine, Durham, NC, USA.
authors.forename: Renato D
authors.initials: RD
authors.lastname: Lopes
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D001022:Aortic Valve Insufficiency / Q000150:complications*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008944:Mitral Valve Insufficiency / Q000150:complications*; D009025:Morpholines / Q000627:therapeutic use*; D013876:Thiophenes / Q000627:therapeutic use*; D014859:Warfarin / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D009025:Morpholines; D013876:Thiophenes; D014859:Warfarin